Operating cash flow decreased 120.3%
Operating cash flow changed -120.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$4.0M→-$8.9M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NRXP financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 817.0%
Cash & equivalents changed +817.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$2.9M→$26.7M4 prior comparisons
Current assets increased 535.3%
Current assets changed +535.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$4.6M→$29.2M4 prior comparisons
Total assets increased 606.1%
Total assets changed +606.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$4.8M→$34.2M4 prior comparisons
Working capital increased 86.8%
Working capital changed +86.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$35.9M→-$4.7M4 prior comparisons
Shares outstanding increased 119.7%
Shares outstanding changed +119.7% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
19,705,077→43,295,7677 prior comparisons
Operating income decreased 74.4%
Operating income changed -74.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$3.7M→-$6.5M3 prior comparisons
Working capital / assets moved 72747 bp higher
Working capital / assets changed +72747 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-741.28%→-13.81%4 prior comparisons
Current ratio increased 658.6%
Current ratio changed +658.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
0.11→0.864 prior comparisons
Research & development increased 114.4%
Research & development changed +114.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$987,000→$2.1M3 prior comparisons
Stock-based compensation increased 107.5%
Stock-based compensation changed +107.5% from the comparable as-filed period.
$67,000→$139,0003 prior comparisons
Current liabilities decreased 16.3%
Current liabilities changed -16.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$40.5M→$33.9M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.